Australia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
08/09/2026 03:29
BUZZ-Australia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone ** Shares of Australia's OncoSil Medical OSL.AX rise as much as 19.2% at A$1.120, on track for their biggest intraday pct gain since July 3
** Stock hits its highest level since September 2
** The medical device company announces treatment of 100-th patient with unresectable locally advanced pancreatic using its OncoSil device in Spain
** Adds that this milestone demonstrates the progress made in one of company's key European markets as well as growing engagement from clinicians and hospitals across Spain, CEO Nigel Lange says
** Stock up 14% YTD, including sessions' moves
(Reporting by Shravya Marakini in Bengaluru)
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval